Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-02-006452
Filing Date
2002-06-25
Accepted
2002-06-25 14:49:38
Documents
6
Effectiveness Date
2002-06-25

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC y61737sv8.txt S-8 20830
3 NON-QUALIFIED STOCK OPTION PLAN y61737exv4w1.txt EX-4.1 26055
4 2001 INCENTIVE AND NON-QUALIFIED STOCK OPTION PLAN y61737exv4w2.txt EX-4.2 37810
5 OPINION OF SAUL EWING LLP. y61737exv5.txt EX-5 2284
6 CONSENT OF KPMG LLP y61737exv23w1.txt EX-23.1 770
7 CONSENT OF ERNST & YOUNG LLP y61737exv23w2.txt EX-23.2 876
  Complete submission text file 0000950123-02-006452.txt   90896
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-91118 | Film No.: 02686412
SIC: 2835 In Vitro & In Vivo Diagnostic Substances